Product Information
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0983 per EA under NDC 68382085601. Its NADAC has been published 360 times since Oct 2, 2019.
FDA first approved this application on Jun 29, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 37.5 mg/1; mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382085601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENEApproval Type
Generic (ANDA)
FDA Application
ANDA208360FDA Approved
6/29/2018
TE Code
AB
On Market Since
9/4/2018
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has been published 360 times since Oct 2, 2019, and over the history we have for it it has declined 20.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0983 per EA |
|---|---|
| All-time high | $0.1242 (Oct 16, 2019) |
| All-time low | $0.0721 (Nov 20, 2024) |
| 52-week high | $0.0983 |
| 52-week low | $0.0915 |
| Median price | $0.0976 |
| Average price | $0.0983 |
| Largest weekly change | -29.0% (Nov 20, 2024) |
| Weeks tracked | 360 |
| Tracking since | Oct 2, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0983 per EA (NDC 68382085601), effective Aug 19, 2026.
How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has declined 20.9%. It has been tracked across 360 weekly CMS publications since Oct 2, 2019.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
Since Oct 2, 2019, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB has ranged from a low of $0.0721 (Nov 20, 2024) to a high of $0.1242 (Oct 16, 2019), with a median of $0.0976 per EA.
Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB?
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG TB (NDC 68382085601) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.